CAS NO: | 841-67-8 |
包装 | 价格(元) |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | (S)-Thalidomide ((S)-(-)-Thalidomide) is the S-enantiomer of Thalidomide. (S)-Thalidomide has immunomodulatory, anti-inflammatory, antiangiogenic and pro-apoptotic effects[1][2][3]. (S)-Thalidomide induces teratogenic effects by binding tocereblon(CRBN)[4]. | ||||||||||||||||
IC50& Target | Apoptosis[1] | ||||||||||||||||
体外研究 (In Vitro) | (S)-Thalidomide treatment results in a reduction in cell viability in U266 cells with an IC50of 362 μM[1]. Cell Viability Assay[1]
Apoptosis Analysis[1]
| ||||||||||||||||
体内研究 (In Vivo) | Thalidomide does cause limb reduction defects in chick embryos as long as the embryos are directly exposed to the drug. The most useful techniques are implanting Thalidomide-soaked beads into the embryo immediately adjacent to the limb territory or soaking presumptive chick limb territories in Thalidomide and then grafting the explants to a host embryo celom. Thalidomide affects the chick limb grafted to a host embryo in a dose response fashion. Furthermore, (S)-Thalidomide is more teratogenic than (R)-Thalidomide[1]. | ||||||||||||||||
分子量 | 258.23 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C13H10N2O4 | ||||||||||||||||
CAS 号 | 841-67-8 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) | ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 83.33 mg/mL(322.70 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |